No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Hester Biosciences Limited, established in 1987 with its headquarters in Ahmedabad, India, operates as a key manufacturer and international distributor of veterinary vaccines and animal wellness products. The company organizes its extensive portfolio into specialized divisions, including Poultry Healthcare, Animal Healthcare, and Petcare. For poultry, it offers a comprehensive array of vaccines addressing various ailments such as Newcastle disease, infectious bronchitis, fowl pox, egg drop syndrome, and Marek's disease. Its livestock vaccine selection covers crucial conditions like goat pox, peste des petits ruminants, brucellosis, and lumpy skin disease. Beyond immunization, Hester Biosciences supplies a wide range of animal health solutions, comprising biosecurity and therapeutic formulas, herbal and homeopathic remedies, and nutritional feed supplements. The pet care segment provides products for digestive health, pain relief (NSAIDs), joint support, parasite elimination, coat nourishment, grooming, and anti-infective treatments. Additionally, the company produces diagnostic kits utilizing enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR) technologies.
www.hester.inNo one on the platform currently holds HESTERBIO.BO.
No tracked institution reports a position in HESTERBIO.BO as of their last filing.
No one on the platform has traded HESTERBIO.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| HESTERBIO.BOHester Biosciences Limited | $2184.70 | +0.78% | $18.6B | — |
| BAJAJHCARE.BOBajaj Healthcare Ltd | $320.95 | +0.19% | $10.7B | — |
| BAJAJHCARE.NSBajaj Healthcare Ltd | $321.10 | +0.06% | $10.8B | — |
| BLISSGVS.BOBliss GVS Pharma Limited | $679.90 | -0.94% | $72.5B | — |
| BLISSGVS.NSBliss GVS Pharma Limited | $680.50 | -0.65% | $72.2B | — |
| JAGSNPHARM.BOJagsonpal Pharmaceuticals Limited | $228.10 | +1.11% | $15.0B | — |
| JAGSNPHARM.NSJagsonpal Pharmaceuticals Limited | $228.28 | +1.08% | $15.0B | — |
Source: Financial Modeling Prep · peers by sector/industry